hrs4r
 I want to donate
Firma
ESTER OLIVA-POCH
Position
Investigador/a Pre-doctoral – R1
Predoctoral Researchers – R1

Projectes

Codi oficial: 2024_GECP_CMF Start date:01/12/2024 Data fi: 30/11/2026 Investigador/a principal: CLAUDIA MONTAÑES FERRER Organisme finançador: GRUPO ESPAÑOL DE CANCER DE PULMON
Codi oficial: Premio mejor póster SEOM2024 Start date:01/01/2025 Data fi: 31/12/2025 Investigador/a principal: ELISABET BUJONS BUSCARONS, ESTER OLIVA POCH Organisme finançador: SOCIEDAD ESPAÑOLA DE ONCOLOGÍA MÉDICA (SEOM)

Publicacions

Sais, E, PLUJA CASTELLANO, ANNA, MONTAÑES FERRER, CLAUDIA, Bujons-Buscarons, E, PINEDA RIVERO, FRANCISCO JAVIER, Iguaran A, Roselló À, Hernández Martínez A, Teixidor-Vilà, E, ROMERA, ALVARO, Bosch-Barrera, J, ERASO URIÉN, ARANTXA, Oliva-Poch E

1062P Effect of the immunological circadian rhythm on the treatment of locally advanced non-small cell lung cancer treated with consolidation immunotherapy

ANNALS OF ONCOLOGY, 2024, 35, 1-1 dx.doi.org/10.1016/j.annonc.2024.08.1120
Sant M, Daidone C, Innos K, Marcos-Gragera R, Vanschoenbeek K, Barranco MR, Poch EO, Lillini R, Lung Cancer HR Study Working Group

Patterns of care and survival for lung cancer: Results of the European population-based high-resolution study.

Frontiers In Epidemiology, 2023, 3, 1109853-1109853 dx.doi.org/10.3389/fepid.2023.1109853
Niksic M, Redondo-Sanchez D, Chang YL, Rodriguez-Barranco M, Exposito-Hernandez J, Marcos-Gragera R, Oliva-Poch E, Bosch-Barrera J, Sanchez MJ, Luque-Fernandez MA

The role of multimorbidity in short-term mortality of lung cancer patients in Spain: a population-based cohort study

Bmc Cancer, 2021, 21, 1048-1048 dx.doi.org/10.1186/s12885-021-08801-9
Bosch-Barrera J, Oliva E, Sais E, Vásquez CA, Roselló A, Menéndez JA

Hyperprogression after first dose of immunotherapy in a patient with radioresistant metastasis from nonsmall cell lung cancer

ANTI-CANCER DRUGS, 2019, 30, 1067-1070 dx.doi.org/10.1097/CAD.0000000000000837

Formulari de contacte

About IDIBGI!

menu